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During the secretory phase of their life-cycle, ameloblasts are highly specialized secretory
cells whose role is to elaborate an extracellular matrix that ultimately confers both form
and function to dental enamel, the most highly mineralized of all mammalian tissues.
In common with many other “professional” secretory cells, ameloblasts employ the
unfolded protein response (UPR) to help them cope with the large secretory cargo of
extracellular matrix proteins transiting their ER (endoplasmic reticulum)/Golgi complex
and so minimize ER stress. However, the UPR is a double-edged sword, and, in
cases where ER stress is severe and prolonged, the UPR switches from pro-survival
to pro-apoptotic mode. The purpose of this review is to consider the role of the
ameloblast UPR in the biology and pathology of amelogenesis; specifically in respect
of amelogenesis imperfecta (AI) and fluorosis. Some forms of AI appear to correspond to
classic proteopathies, where pathological intra-cellular accumulations of protein tip the
UPR toward apoptosis. Fluorosis also involves the UPR and, while not of itself a classic
proteopathic disease, shares some common elements through the involvement of the
UPR. The possibility of therapeutic intervention by pharmacological modulation of the
UPR in AI and fluorosis is also discussed.
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INTRODUCTION
Amelogenesis involves the incremental secretion of a self-assembling extracellular protein matrix
(enamel matrix) on to the pre-existing dentine surface by columnar secretory ameloblasts. The
enamelmatrix is overwhelmingly (>90%) composed of proteins derived by extracellular proteolysis
of alternatively spliced products of the amelogenin gene (AMELX/Y in humans; Amelx in rodents)
(Brookes et al., 1995). Other, far less abundant, matrix proteins that are secreted during the
secretory phase of amelogenesis include: enamelin (ENAM), ameloblastin (AMBN) and matrix
metallopeptidase 20 (MMP20) (Moradian-Oldak, 2012; Bartlett, 2013). AMELX, ENAM, and
AMBN are generally regarded as structural components of the enamel matrix whereas MMP20,
present in catalytic amounts, is responsible for the proteolytic processing of AMELX, ENAM, and
AMBN. Enamel is partially mineralized during the secretory phase. Extremely elongated crystallites
of hydroxyapatite, originating at the enamel-dentine junction, grow in length (c-axis growth)
surrounded by enamel matrix proteins that are newly secreted by the ameloblasts as they migrate
away from the enamel dentine junction. Secretory stage ameloblasts have the typical characteristics
of a specialized secretory cell, including numerousmitochondria and a well-developed endoplasmic
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reticulum (ER)/Golgi complex (Reith, 1961). These adaptations
allow the ameloblasts to cope with their large secretory load as
they incrementally secrete the enamel matrix.
Enamel crystallites are organized into bundles (the so-called
enamel prisms or rods) which are interspersed with inter-
prismatic enamel crystals that together delineate the enamel
ultrastructure; a process directed by the ameloblasts’ specialized
Tomes’ process from which the secretory cargo is elaborated
(Smith, 1998). The function of the enamel matrix and its
component parts is still not fully understood but the consensus
view is that it is involved with the nucleation of the enamel
crystallites, the control of their subsequent preferential c-axis
growth, and their structural organization into prisms and
inter-prismatic enamel. Once the ameloblasts have secreted
the required thickness of enamel, matrix secretion ceases. The
ameloblasts become shortened and less columnar and lose their
Tomes’ processes. This marks the end of the secretory phase and
the beginning of the maturation phase (Smith, 1998) which is
further characterized by ameloblasts up-regulating the expression
and secretion of a number of maturation stage-specific proteins
including kallikrein-related peptidase 4 (KLK4) (Bartlett, 2013),
amelotin (AMTN) (Iwasaki et al., 2005), and odontogenic
ameloblast-associated protein (ODAM) (Nishio et al., 2010).
KLK4 is a serine protease that quickly degrades the spectrum
of proteins comprising the secretory stage matrix, facilitating
their ultimate removal from the tissue by ameloblast endocytosis
(Lacruz et al., 2013). As the enamel matrix is removed, it is
replaced by fluid into which the ameloblasts actively transport
mineral ions which drive the growth of the enamel crystallites in
width and thickness so that they eventually occlude most of the
tissue volume.
The functional importance of the enamel matrix proteins
in amelogenesis is evidenced by the effects of mutations
in their respective genes on the enamel phenotype, which
can result in amelogenesis imperfecta (AI), characterized by
biomineralization defects of enamel (Smith et al., 2017). Several
studies have examined the potential effects of such mutations
on events occurring in the enamel extracellular matrix itself,
including protein-protein interactions and enamel matrix self-
assembly (Lakshminarayanan et al., 2010; Zhu et al., 2011) and
also protein-mineral interactions (Zhu et al., 2011). Certainly,
perturbation of these processes would be expected to give rise to
enamel biomineralization defects and therefore AI, including, for
example, a complete failure to produce enamel, the production
of pathologically thin or under-mineralized enamel or enamel
in which the ultrastructural arrangement of the crystallites
is affected. However, recent data have suggested that intra-
cellular events related to the so-called unfolded protein response
(UPR) may also play an important role in enamel biology and
pathology—including AI and fluorosis.
The UPR is a signaling pathway that has evolved to allow
cells to manage their secretory load under normal physiological
and pathological conditions to maintain proteostasis in the
endoplasmic reticulum (ER) (Hetz et al., 2015). Failure to
maintain proteostasis can lead to ER stress which is a factor in
many diseases (Kopito and Ron, 2000; Ozcan and Tabas, 2012).
Our aim is to review the literature detailing the way in which
secretory ameloblasts cope with their large secretory burden
by utilizing the UPR in a similar way to other “professional”
secretory cells (such as pancreatic islet cells and plasma cells) in
order to maintain ER proteostasis and reduce ER stress levels.
We begin with a brief introduction to ER stress and the UPR
before moving on to discuss how ameloblasts employ the UPR to
cope with ER stress in both the absence and presence of genetic
mutations. The evidence supporting the hypothesis that ER stress
can be an etiological factor in both AI and fluorosis will be
discussed along with possible therapeutic options for targeting
ameloblast ER stress to ameliorate associated enamel pathologies.
ER STRESS AND THE UNFOLDED
PROTEIN RESPONSE (UPR)
The ER is responsible for trafficking all nascent proteins destined
for secretion or insertion into a cellular membrane from their
synthesis at the ribosome to the Golgi apparatus. The lumen
of the ER contains an assortment of resident ancillary proteins
(chaperones) that direct the folding of nascent polypeptides
to maximize the probability that a nascent protein attains its
correct functional 3-dimensional conformation. In addition,
oxidoreducatase enzymes ensure that disulphide bond formation
is regulated to inhibit random disulphide bond formation that
if allowed could result in mis-folding. However, the molecular
policing mechanisms that prevent protein mis-folding can fail.
In this case, the protein may be permitted to access and become
trapped in some low-energy state with a conformation that
may not be biologically active or in some cases may promote
pathological intracellular protein aggregation or be frankly
cytotoxic (Dobson, 2003; Gregersen et al., 2006). Up to 30% of
newly synthesized wild-type (WT) proteins can spontaneously
mis-fold and fail to achieve their proper conformation (Schubert
et al., 2000). Mutated proteins may show an even greater
propensity to mis-fold and aggregate. This is the etiological basis
that underpins many so-called proteopathic or conformational
diseases (e.g., Parkinson’s disease, Alzheimer’s disease, cystic
fibrosis, Huntington’s disease, some cancers, diabetes and
myofibrillar myopathies) (Selkoe, 2003; Lin et al., 2008; Valastyan
and Lindquist, 2014; Oakes and Papa, 2015). Not surprisingly,
cells have therefore evolved an active quality control system that
monitors client proteins transiting through the ER. This quality
control system recognizes aberrant client proteins, (whether
spontaneously mis-folded WT or mis-folded mutated proteins)
and acts to restore ER homeostasis thus alleviating ER stress.
However, if the stress cannot be alleviated, the cell is directed
toward apoptosis. The detection of mis-folded proteins is carried
out by three sensor proteins that span the ER membrane: PERK,
IRE1, and ATF6 (see below).
ER Stress Can Activate the UPR Which
Attempts to Restore Proteostasis
Activation of the trans-ER membrane sensors triggers an
integrated signaling pathway that initially attempts to restore ER
homeostasis by: (i) reducing the secretory load, (ii) increasing the
folding capacity of the ER by up-regulating chaperone expression
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and increasing ER volume, and (iii) increasing ER-associated
protein degradation (ERAD) (Schroder and Kaufman, 2005).
When ER stress is low, the sensors appear to be inactivated
by their binding of GRP78 (BiP, HSPA5); present in the ER
where it also functions as a chaperone, binding to cargo proteins.
Mis-folded proteins in the ER lumen associate with GRP78
such that GRP78 is increasingly dissociated from the sensors,
allowing them to become active and trigger the UPR (Schroder
and Kaufman, 2005; Malhotra and Kaufman, 2007a). However,
GRP78 may not be the main regulator in the case of sensor IRE1,
which may be activated by direct interaction with mis-folded
proteins (Credle et al., 2005; Gardner and Walter, 2011) that is
independent of its GRP78 binding domain (Kimata et al., 2004).
The initial UPR is pro-survival in nature, helping cells cope
with a heavy secretory load even in the absence of any protein
mutations. However, if the ER stress cannot be relieved, then the
UPR, acting as a “double edged sword” (Malhotra and Kaufman,
2007b) switches to pro-apoptotic mode (Fribley et al., 2009).
The decision to enter apoptosis arises through the integration
of the multiple signaling outputs from the UPR; it does not
involve a single event or signaling pathway (Rutkowski et al.,
2006). In effect, the UPR is a graded response whose effect on
the cell appears to depend on cell context, including the nature
and duration of the stimulus causing the ER stress and the
differential activation of the sensors under specific forms of ER
stress, including their differential regulation by protein co-factors
other than GRP78. The UPR is further modulated downstream
allowing fine-tuning under specific circumstances (Hetz, 2012).
The UPR in Pro-Survival Mode—Adapting
to ER Stress
A detailed description of the signaling pathways triggered by ER
stress is beyond the scope of this review but the role of the three
sensors of the UPR in the pro-survival adaptive response will be
discussed briefly below and is summarized in Figure 1.
IRE1
On activation, IRE1 oligomerizes and undergoes auto-
phosphorylation, activating its endoribonuclease activity to
drive the unconventional splicing of XBP1 mRNA (Yoshida
et al., 2001; Prischi et al., 2014). Spliced XBP1 mRNA encodes
a transcription factor that interacts with ER stress response
elements to up-regulate UPR target genes such as chaperones
(e.g., GRP78 and GRP94 (Lee et al., 2003), components of the
ERAD system, genes associated with ER and Golgi expansion
(lipid synthesis) (Lee et al., 2003; Ron and Walter, 2007; Hetz
et al., 2011) and IRE1 itself (Tsuru et al., 2016). IRE1 also degrades
specific ER-localized mRNAs (regulated Ire1-dependent decay)
in an attempt to provide immediate relief from the translational
load entering the already stressed ER during the initial phase of
ER stress (Hollien and Weissman, 2006; Han et al., 2009).
PERK
On activation, PERK dimerizes and undergoes auto-
phosphorylation. Activated PERK phosphorylates its
downstream target, eIF2α. Phosphorylated eIF2α binds the
guanine nucleotide exchange factor eIF2β, inhibiting assembly
of the 43S translation initiation complex. This process effectively
reduces general protein translation, thus reducing the secretory
load (Harding et al., 2000). However, eIF2α-P selectively increases
the translation of transcription factor ATF4, which targets a wide
range of ER stress response elements including those involved in
protein folding, assembly and metabolism (Dey et al., 2010), and
as described below, apoptosis.
ATF6
On activation, ATF6 is trafficked to the Golgi where the cytosolic
N-terminal domain is proteolytically cleaved (Ron and Walter,
2007). The cleaved ATF6 N-terminal domain is a transcription
factor that translocates to the nucleus where it interacts with ER
stress response elements to activate multiple UPR target genes
coding elements of the ERAD system, chaperones such as GRP78
and the UPR-associated transcription factors AFT4 and Xbp1
(Yoshida et al., 2001). PERK activation enhances ATF6 synthesis
and its trafficking to the Golgi for proteolytic activation which
is promoted by ATF4 (Teske et al., 2011). The ATF6 pathway
appears to overlap functionally to some extent with the PERK and
IRE1 pathways (Wu et al., 2007).
The UPR in Pro-Apoptotic
Mode—Capitulating to ER Stress
At some point during ER stress, a decision is made to abandon
promotion of cell survival in favor of apoptosis. The timing
of this decision, and the level of stress required to trigger the
switch to pro-apoptotic mode, appear to depend on the specific
nature of the stress encountered and the cell context but the
decision arises following close scrutiny of the integrated signals
originating from the three sensor-led arms of the UPR and the
cross-talk between them as the UPR evolves (Tabas and Ron,
2011; Chen and Brandizzi, 2013; Moore and Hollien, 2015).
The IRE1 arm of the UPR appears to be the central
player in directing a cell away from survival and toward
apoptosis (though all arms of the UPR can activate downstream
apoptotic pathways). IRE1 endoribonuclease activity can be
used to manipulate the UPR response by finely controlling
the degradation of specific target mRNAs (Han et al., 2009); a
process enhanced when PERK is activated (Moore and Hollien,
2015), emphasizing the complex cross-talk underpinning the
UPR. Under unrelieved ER stress, XBP1mRNA splicing increases
along with the regulated IRE1-dependent decay of ER-localized
mRNAs encoding for ER cargo. This depletes the ER cargo
including critical cell surface bound traffic (e.g., membrane
bound receptors) and ER resident chaperones involved in
protein folding. As a result, stress levels are tipped beyond a
critical threshold, triggering the pro-apoptotic response (Han
et al., 2009; Coelho and Domingos, 2014). In addition, IRE1-
dependent decay targets specific microRNAs that repress the
translation of caspase-2 (Upton et al., 2012), an executioner
caspase implemented in apoptosis and linked to ER stress (Fava
et al., 2012).
The molecular details of how the UPR finally brings about
apoptosis are still the subject of intense research, driven in part
by the fact that the UPR plays a pivotal role in numerous human
diseases. A brief, and by no means complete, overview of the
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FIGURE 1 | Diagram summarizing an outline of the cell signaling occurring during ER stress and the UPR. Full details are provided in the text but in brief, titration of
GRP78 by misfolded proteins in the ER lumen causes phosphorylation (activation) of the ER membrane-spanning stress sensors IRE1, PERK, and AFT6. This
unleashes an interconnected downstream signaling cascade of transcription factors that initially reduces the translational load by mRNA degradation and inhibition of
translation. A series of ES stress response elements (ERSE) are targeted resulting in the transcription of genes that aid the cell cope with its secretory load and
promote cell survival. In cases where the ER stress is unrelieved, the pro-apoptotic transcription factor CHOP is expressed. Together with the concerted activity of
P38 MAPK and JNK (activated by IRE1 kinase activity), CHOP promotes apoptosis through the BAX/BAK mediated permeation of mitochondrial outer membranes.
IGF-1 receptor signaling inhibits apoptosis by indirectly controlling the activation of P38 MAPK and JNK.
events occurring following the decision to commit to apoptosis
is given below.
The transcription factor CHOP is an important UPR target
gene. CHOP expression in stress-free cells is almost undetectable
but it is upregulated by ATF4 (Su and Kilberg, 2008), which
as described previously is itself induced following activation of
PERK and AFT6 in cells undergoing ER stress (Tabas and Ron,
2011; Li et al., 2014). CHOP is post-translationally activated
by phosphorylation mediated via the stress kinase p38MAPK,
which is itself activated by IRE1 kinase activity. Activated CHOP
up-regulates expression of pro-apoptotic gene products such as
BIM (Puthalakath et al., 2007) whilst decreasing expression of
anti-apoptotic gene products such as BCL-2 (Li et al., 2014). IRE1
kinase activity also activates a second stress kinase, JNK, which in
turn can phosphorylate both BIM and BCL-2 to regulate their
activity.
BIM and BCL-2 are exemplar members of a wider family of
proteins that facilitate and inhibit the triggering of apoptosis
respectively. In their non-phosphorylated states, BCL-2 is
actively anti-apoptotic and BIM is inactive. On phosphorylation
by JNK, BCL-2 loses its anti-apoptotic properties while BIM
becomes actively pro-apoptotic. Under these conditions, the
constitutively expressed factors BAX and BAK act in concert to
trigger mitochondrial membrane disruption and the release of
factors including cytochrome c that initiate the final executioner
caspase cascade that leads to cell death (Nomura et al., 1999; Ow
et al., 2008; Tabas and Ron, 2011). BAK is usually resident on
the outer mitochondrial membrane but BAX translocates from
the cytoplasm to the outer mitochondrial membrane following
phosphorylation by p38MAPK or JNK (Kim et al., 2006; Ow et al.,
2008), linking BAX translocation and apoptosis directly to IRE1.
The regulation of BAX and BAK activity is of prime importance
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and it is clear even from the simplified account given above that
the three arms of the UPR work in concert to tightly regulate
BAX and BAK activity with numerous check points and gates in
place to ensure that a point of consensus has been reached prior
to committing the cell to apoptosis.
WILD-TYPE SECRETORY STAGE
AMELOBLASTS RELY ON THE UPR IN
PRO-SURVIVAL MODE TO MAINTAIN
THEIR SECRETORY OUTPUT
Specialized secretory cells, including plasma cells, pancreatic
cells, hepatocytes and osteoblasts face ER stress even under
normal conditions simply by virtue of their high secretory
load and consequently rely on the UPR acting in pro-survival
mode (Moore and Hollien, 2012). Secretory ameloblasts can
be regarded as specialized secretory cells and share typical
characteristics such as a prominent ER/Golgi network during
the secretory stage. An early indication that the UPR is normally
active in secretory stage ameloblasts was the finding that IRE was
present its activated form (Kubota et al., 2005). As described in
previously, a primary outcome of an active UPR is to increase
the volume of ER to increase the handling capacity of the
cell’s secretory pathway. The volume occupied by the ER in
WT pre-secretory ameloblasts increases by a factor of around
3.3 by the time the ameloblast has reached the end of the
secretory stage (Tsuchiya et al., 2008). Furthermore, there is a
dramatic reduction in immunohistological staining for activated
phosphorylated IRE1 in maturation-stage ameloblasts compared
to secretory-stage ameloblasts which is a reflection of the greatly
reduced secretory load transiting the ER in maturation-stage
ameloblasts (Tsuchiya et al., 2008). These authors also reported
that expression of spliced Xbp1 mRNA was five times greater
in secretory enamel organ cells compared to maturation stage
enamel organ, indicating that IRE1 activation had indeed
triggered the UPR in the secretory ameloblasts (Tsuchiya
et al., 2008). These data are important as they indicate that
WT secretory ameloblasts are stressed by their secretory load
under normal conditions and require the UPR to help manage
the situation. The prominent client protein in the secretory
ameloblast pathway is amelogenin; a hydrophobic protein that
is well known for its propensity to self-assemble/aggregate.
Molecular cross-linking studies showed that amelogenin begins
to self-assemble during its transit through the ameloblast
secretory pathway (Brookes et al., 2006) and the regulation of
these intramolecular interactions may well require sustained
input from the folding machinery under the influence of UPR
signaling.
As described previously, CHOP expression is a marker
for UPR-induced apoptosis and is undetectable in stress-free
cells. Despite evidence that the UPR operates in pro-survival
mode in the secretory stage of amelogenesis, Chop expression
was detected in secretory stage enamel organs of WT mice by
quantitative PCR (Brookes et al., 2014) suggesting that even WT
ameloblasts may be on their way toward an apoptotic end-point.
It was not clear from this ensemble data whether the level of
Chop expression represented relatively low level expression in all
ameloblasts or whether it reflected relatively high expression in a
sub-population of cells. Why is it that WT secretory ameloblasts
do not succumb to apoptosis given that they appear to be
expressing Chop especially as rodent WT ameloblasts have been
described as “hard wired” for apoptosis (Joseph et al., 1999)? It
has been proposed that activation of IGF-1 receptors, expressed
by ameloblasts throughout amelogenesis, except for a short
window during the transition from the secretory to maturation
stage (Joseph et al., 1994), inhibits pro-apoptotic events by
modulating BCL-2 and BAX or by directly inhibiting caspase
3 activation (Joseph et al., 1999). These events are downstream
of CHOP (see Figure 1) so that even when CHOP is expressed,
IGF-1 signaling may prevent the final commitment to apoptosis.
Later work confirmed that IGF-1 receptor activation inhibits JNK
and P38 MAPK activation (Galvan et al., 2003), both of which
are involved in committing the cell to apoptosis by modulating
BCL-2, BIM and BAX phosphorylation at a point downstream of
CHOP expression (see Figure 1). We can therefore hypothesize
that the UPR assists WT secretory ameloblasts to cope with
their heavy secretory load but also primes the most stressed
cells for apoptosis while IGF-1 signaling prevents the cells from
taking the final steps that commit to apoptosis. An estimated
25% of ameloblasts abruptly succumb to apoptosis at the end
of the secretory stage (Smith and Warshawsky, 1977). We
hypothesize that the most stressed secretory stage ameloblasts
are prevented from undergoing apoptosis by IGF-1 signaling
during secretion, but, during the transition from secretion to
maturation, when IGF-1 receptor expression ceases, the brake
on apoptosis is released and pre-disposed ameloblasts rapidly
undergo apoptosis. However, as IGF-1 receptor expression
increases again once ameloblasts enter the maturation stage
proper (Joseph et al., 1994), the brake on ameloblast apoptosis
is re-applied. IGF-1 signaling also up-regulates the expression of
the chaperone GRP78 independently of the UPR which enhances
the folding capacity of the ER and provides additional protection
against ER stress (Novosyadlyy et al., 2008). The importance of
IGF-1 in amelogenesis is emphasized by the fact that ameloblasts
express IGF-1 in addition to the IGF-1 receptor, establishing an
autocrine signaling loop (Joseph et al., 1996).
Given that WT secretory ameloblasts are already using the
UPR to help cope with ER stress generated by their demanding
secretory function, the cells are already on a path that can
lead to an apoptotic end-point. This raises the question as to
whether there is a role for the ameloblast UPR where enamel
matrix proteins (or others) are affected by genetic mutations and
generate even more intense levels of ER stress. The net effects
of the UPR in the presence of an enamel protein mutation may
be relatively mild (e.g., due to reduced translation of enamel
proteins) or more severe (e.g., due to ameloblast apoptosis). The
next section will review the evidence that mutations in enamel
matrix proteins can indeed cause AI driven by ER stress.
ER STRESS AND THE UPR AS AN
ETIOLOGICAL FACTOR IN AI
Classically, AI has been approached from the perspective that
mutations in genes encoding for secreted enamel matrix proteins
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would impact on protein functionality and behavior within the
extracellular matrix itself. For example, studies have shown that
certain AMELX mutations can affect amelogenin self-assembly
(Paine et al., 2002; Zhu et al., 2011) and the ability to adsorb onto
hydroxyapatite and control crystal growth (Zhu et al., 2011). It
is extremely likely therefore that dysfunction of mutated enamel
proteins in the extracellular compartment can drive AI. However,
in recent years it has become clear that in some specific cases,
AI may be associated with the intracellular phenomenon of
ameloblast ER stress and UPR activation.
The first evidence that ER stress could drive AI came
from detailed phenotyping of a mouse model exhibiting an
Amelxp.(Y64H) mutation (Barron et al., 2010; Brookes et al., 2014).
More recently mouse Enamp.(S55I) and human ENAMp.(L31R)
mutations have also been associated with ameloblast ER stress
(Brookes et al., 2017). ENAM is expressed at very low levels
compared to AMELX and is biochemically distinct—in mice
being over seven times the molecular weight of AMELX and
more basic in nature (Hu et al., 1998). The two proteins may
have originated from a common ancestral gene (Sire et al., 2006)
but no longer share sequence homology, suggesting divergent
functional roles. It is therefore somewhat surprising that enamel
from female mice heterozygous for Amelxp.(Y64H) (there is
no AMELY transcript in rodents) closely phenocopies mice
heterozygous for Enamp.(S55I).
Incisor enamel from heterozygous mice of both genotypes
revealed an unusual phenotype in which the first 30–50µm of
initially secreted incisor enamel (i.e., the inner enamel adjacent
to the dentine) exhibited the decussating prismatic structure
characteristic of WT rodent incisor enamel but this was overlaid
with subsequently secreted, structurally abnormal, aprismatic
enamel (Brookes et al., 2014, 2017). This shared structural
phenotype suggests a common underlying etiology despite
the presumed functional differences between AMELX and
ENAM. Secretory-stage ameloblasts of both genotypes exhibited
abnormal retention of enamel matrix proteins, indicating
a compromised secretory pathway. Notably, ameloblasts in
both Amelxp.(Y64H) and Enamp.(S55I) animals showed a clear
upregulation of markers indicative of ER stress and an
activated UPR (e.g., Grp78, Xbp1, Grp94, and Atf4). During
the early secretion stage, ameloblasts in affected mice were
present as an ordered monolayer characteristic of WT animals
and produced a structurally normal inner layer of enamel.
However, in the later stages of secretion, the ameloblast
monolayer became more disorganized, coincident with the
loss of normal prismatic structure. These observations were
interpreted in terms of the UPR initially acting in pro-survival
mode, which maintained a functional ameloblast monolayer
and allowed the cells to produce a structurally normal initial
layer of enamel in both mutant genotypes. However, as the
UPR signal evolved, ameloblasts from female mice expressing
the Amelxp.(Y64H) (comprising ∼50% of the total ameloblast
population due to random X-chromosome deactivation) were
directed toward apoptosis as evidenced by increased Chop
expression, which severely disrupted the ameloblast monolayer
leading to the production of structurally abnormal enamel.
In contrast, Chop expression in enamel organs from mice
heterozygous for Enamp.(S55I) remained at WT levels and it
was assumed that the evolving UPR in these animals was
up-regulated but failed to reach the tipping point required
to trigger apoptosis. Nevertheless, the response was evidently
sufficient to compromise the integrity of the ameloblast
monolayer which resulted in the production of a structurally
abnormal outer layer of enamel. This section is summarized in
Figure 2.
Secretory stage ameloblasts in hemizygous male mice
carrying the Amelxp.(Y64H) mutation and mice homozygous for
Enamp.(S55I) exhibited increased expression of the pro-apoptotic
transcription factor Chop compared to WT animals. Animals of
both mutant genotypes did not produce a recognizable enamel
layer. The failure to produce any enamel may have been related
to the fact that the UPR evolved more quickly away from a pro-
survival mode. However, another possibility is that insufficient
mutated AMELX or ENAM molecules were secreted into the
matrix to support amelogenesis and even if they were, the
mutation could have impacted on their extracellular function.
What about the anti-apoptotic role of IGF-1 in these animals,
which should be unaffected by mutations in the Amelx and Enam
genes? We can only assume that if the ER stress reaches a critical
intensity, the UPR can circumvent the “protection” provided by
IGF-1 receptor signaling. The details of how this can be achieved
are unclear but it may be simply due to the significant increase
in Chop expression in the presence of a mutation that overcomes
the anti-apoptotic effects of IGF-1 receptor signaling.
Finally, is there any evidence that ER stress and the UPR
are etiological factors in human AI? It is virtually impossible
to study amelogenesis in humans due to the obvious issues
in obtaining fresh tooth germs to study. However, due to
the incremental nature of enamel secretion, mature enamel
can provide a temporal record of events that occur during
amelogenesis. This is exemplified by the enamel phenotype for
mice heterozygous for Amelxp.(Y64H) and Enamp.(S55I) described
above. A similar enamel phenotype was recently described
in teeth obtained from an AI patient heterozygous for an
ENAMp.(L31R) mutation. The mature enamel phenotype from the
patient’s exfoliated teeth exhibited the same layer of structurally
normal inner enamel overlaid by a subsequently secreted,
structurally abnormal enamel outer layer (Brookes et al., 2017)
comparable to that described in the mouse models. This is not
unequivocal evidence that the UPR was responsible for AI in this
patient but the developmental record remaining in the enamel
indicates that ameloblast function was severely affected after an
initial period of near-normal secretory activity, reminiscent of an
evolving UPR.
THE ROLE OF THE UPR IN THE
PATHOBIOLOGY OF FLUOROSIS
Early indications that excess fluoride may trigger an ER stress–
like response in ameloblasts were provided by histological reports
suggesting that fluoride disturbs ameloblast intracellular protein
trafficking (Matsuo et al., 1996), including the retention of
ER cargo and the appearance of a dilated ER (Hassunuma
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FIGURE 2 | Scanning electron micrographs of transverse sections through mandibular incisors of (A) WT mice, (B) mice heterozygous for the Amelx p.Y64H mutation
and (C) mice heterozygous for the Enamp.S55I mutation at or near the point of eruption (previously reported by Brookes et al., 2014, 2017). (A) The incremental
secretion of the inner enamel (in the direction indicated by arrow 1) by WT ameloblasts produces the decussating prismatic architecture characteristic of rodent
enamel. (B) In mice heterozygous for Amelxp.Y64H, the ameloblasts begin the incremental secretion of an apparently structurally normal layer of enamel (arrow 1).
However, after about 40 µm of enamel is secreted, the ameloblasts continue to secrete enamel (arrow 2) but they lose the ability to produce the characteristic
decussating prismatic architecture. (C) In mice heterozygous for Enamp.S55I, the ameloblasts similarly secrete a structurally normal layer initially (arrow 1) but enamel
secreted thereafter is structurally abnormal (arrow 2). We hypothesize that the UPR, initially acting in pro-survival mode, supports normal ameloblast function and
allows the ameloblasts to produce an inner layer of decussating enamel. Later, the UPR switches to a more draconian mode and ameloblast function is perturbed
resulting in the secretion of structurally abnormal outer layer of enamel. The dotted line marks demarcation between the inner decussating and outer non-decussating
enamel. (B,C) were derived under Creative Commons CC BY licenses 3.0 and 4.0 (https://creativecommons.org/licenses/) respectively from: Brookes et al. (2014),
and phenotypic rescue using 4-phenylbutyrate; and Brookes et al. (2017). Both published by Oxford University press.
et al., 2007). These observations are consistent with ameloblasts
suffering ER stress but the up-regulation of UPR components
provides unequivocal evidence that the UPR is associated with
the ameloblast response to fluoride. The first such evidence
suggested that fluoride promoted IRE1 activation in maturation
stage ameloblasts in vivo and up-regulated BiP (Grp78), Xbp-1,
and Chop expression in the LS8 ameloblast cell line (Kubota et al.,
2005). The notion that fluoride may impair protein secretion
was further supported when LS8 cells were transfected with
secreted alkaline phosphatase. Fluoride decreased the secretion of
the phosphatase in a dose-dependent manner while intracellular
levels of phosphatase were concomitantly increased, along with
increased levels of activated PERK, phosphorylated eIF2α, and
BiP (GRP78) (Sharma et al., 2008). Later studies using LS8
cells additionally reported that the third stress sensor, ATF6, is
also activated by fluoride (Wei et al., 2013). Increasing levels
of phosphorylated eIF2α were also seen in maturation-stage
ameloblasts in mice provided with increasing concentrations of
fluoride in their drinking water (Sharma et al., 2008, 2010).
However, no increase in levels of phosphorylated eIF2α was
seen in secretory-stage ameloblasts exposed to fluoride in the
same study. The differential effect of fluoride on secretory
stage ameloblasts may be explained by the acid hypothesis
for fluorosis, in which periodic falls in enamel matrix pH
during the maturation stage (but not the secretory stage)
lead to protonation of F− to HF, which greatly increases
its ability to diffuse across cell membranes and so enter
the cytoplasm. At cytoplasmic pH, HF dissociates, resulting
in a HF concentration gradient across the cell membrane.
Trapped cytoplasmic F− would then continue to accumulate
intracellularly to levels that trigger a pathological response
(Sharma et al., 2010).
The possibility that fluoride can disrupt the intracellular
secretory pathway could lead us to conclude that this mechanism
alone triggers the three UPR sensors. However, a known
cytotoxic effect of fluoride is its ability to promote the
accumulation of reactive oxygen species (ROS) by inhibiting free
radical scavenging systems such as those based on glutathione
peroxidase and superoxide dismutase (Chlubek, 2003). ROS are
normally generated by a variety of cellular processes including
mitochondrial electron transport and as a byproduct of disulfide
bond formation in the lumen of the ER (Santos et al., 2009).
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Inability to deal with ROS could lead to redox imbalance in
the ER, a situation that can trigger the UPR via the three ER
stress sensors and/or via ROS-promoted calcium eﬄux (Eletto
et al., 2014). Evidence that fluoride triggers oxidative stress in
ameloblasts was provided by the observation that UCP-2 (an
electron transport uncoupler that provides an adaptive defense
against oxidative stress; Moukdar et al., 2009), was up-regulated
in mice drinking fluoridated water (Suzuki et al., 2014). These
authors suggested that in addition to the effect of fluoride on
the UPR in maturation stage ameloblasts, their function may
be further compromised by energy deficiency caused by the
impact of UCP-2 activity uncoupling electron transport from
ATP synthesis which could impact on crucial maturation stage
processes that require energy, such as the active transport of
mineral ions.
Once activated, how does the UPR actually effect
extracellular events in the maturation stage enamel matrix
under fluorotic conditions? Fluorosis is associated with enamel
hypomineralization and abnormal retention of secretory stage
matrix proteins in maturation stage enamel, where they could
then inhibit secondary crystal growth (Den Besten, 1986; Smith
et al., 1993). Under normal circumstances, KLK4, secreted
during the maturation stage, degrades residual secretory stage
matrix proteins but fluoride does not directly inhibit either KLK4
or its activator proteases (including MMP20) (Tye et al., 2011).
Instead, it appears that fluoride inhibits protein expression in
maturation stage ameloblasts which reduces the amount of
KLK4 available to degrade the residual secretory stage enamel
matrix. As described previously, phosphorylation of eIF2α, by
PERK during the UPR, decreases general protein translation
(Section PERK) and its phosphorylation on exposure to fluoride
in rat maturation stage ameloblasts was shown to downregulate
KLK4 expression, whereas secretory stage expression of AMELX,
AMBN, and MMP20 were unaffected (Sharma et al., 2010). This
prompted the suggestion that fluoride reduced KLK4 expression
and prevented the efficient degradation and removal of residual
secretory stage matrix proteins leading to a pathological
retention of protein in the maturation stage tissue. It has been
suggested that enamel matrix proteins could have a higher
affinity for fluorotic enamel crystals (Tanabe et al., 1988) which
could further compromise the removal of residual matrix
from maturation stage tissue where KLK4 levels are already
depleted.
One final consideration in relation to fluorosis pathobiology
and the role of the UPR is the potential effect of fluoride on
the expression of IGF-1. Since anti-apoptotic IGF-1 signaling
appears to be an important pathway in amelogenesis, it is
interesting that when primary mouse osteoblast cultures were
treated with fluoride, the resulting oxidative stress led to reduced
IGF-1 expression and increased apoptosis (Wang et al., 2011).
Maturation-stage ameloblasts undergo apoptosis under high
fluoride regimes (Kubota et al., 2005) and it is possible that
fluoride not only triggers an apoptotic UPR response but
further enhances that response by simultaneously degrading the
anti-apoptotic effects of IGF-1. This section is summarized in
Figure 3.
TARGETING ER STRESS AND THE UPR AS
A THERAPEUTIC INTERVENTION IN
ENAMEL PATHOLOGIES
ER stress and an up-regulated UPR are now recognized as
etiological factors in numerous serious human diseases (Oakes
and Papa, 2015). Collectively, these diseases can be classed as
proteopathies, or conformational diseases, where protein mis-
folding and aggregation causes loss of ER homeostasis leading to
FIGURE 3 | Schematic diagram summarizing the hypothesized role of the
UPR in fluorosis as described in the text. This impairs the secretory pathway
and promotes a redox imbalance; both can potentially activate the UPR. The
UPR decreases the production of KLK4 and degradation and removal of the
secretory stage matrix is compromised. Retention of the secretory matrix then
inhibits maturation stage crystal growth. In addition, mitochondrial oxidative
phosphorylation is uncoupled from electron transport in an attempt to restore
redox balance. The resulting reduction in ATP synthesis would limit the active
transport of mineral ions into the matrix further compromising maturation stage
crystal growth. A severe fluoride challenge induces apoptosis and it is
hypothesized that this would be mediated by the UPR. Apoptotic signaling
under these circumstances may well be unchecked by anti-apoptotic IGF1
signaling as IGF1 expression is reduced by fluoride. See main text for
references.
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an up-regulated UPR. Much work is ongoing to find therapeutic
strategies to combat proteopathic disease. In general, this is based
on identifying molecules (synthetic chaperones) that can prevent
protein mis-folding and restore normal protein trafficking,
prevent mis-folded proteins activating the three transmembrane
ER stress sensors or modulate the UPR to inhibit apoptosis. A
typical example where ER stress has been targeted therapeutically
is progressive familial intrahepatic cholestasis type 2 caused
by a p.T1210P mutation in the canalicular bile salt export
pump (BSEP). In cultured cells transfected with BSEPp.T1210P,
the BSEP p.T1210P protein was retained in the ER, impeding its
transportation to the canalicular membrane. Addition of the
synthetic chaperone, 4-phenylbutyrate (4-PB), partially corrected
the situation. A child homozygous for the BSEPp.T1210P mutation
was treated with oral 4-PB with a subsequent improvement in
liver function and partial restoration of biliary bile acid secretion.
In this case, it appeared that 4-PB restored the trafficking of
the mutated bile salt export pump to the canalicular membrane,
where, despite the mutation, it was still functional to some
degree. Restoring ER trafficking in this case allowed the mutated
protein to escape the ERAD system (Gonzales et al., 2012). 4-
PB was also able to prevent the aggregation of four different
myocilin mutants in the ER of transfected cells and restore the
secretion of mutant myocilin. This rescued the cell from ER
stress and significantly reduced apoptosis in the transfected cells,
leading the authors to propose that 4-PB could be used as a
therapeutic agent to treat blindness causing primary open-angle
glaucoma (Yam et al., 2007). Topical application of 4-PB eye
drops in mice was later shown to restore the secretion of mutant
myocilin and return intraocular pressure to WT levels (Zode
et al., 2012). In addition to its ability to interact with mis-folded
or aggregated proteins in the ER lumen, 4-PB can also influence
gene expression by its activity as a histone deacetylase inhibitor
that also inhibits the deacetylation of a range of transcription
factors, including NF–κβ. This in turn indirectly affects the
expression of numerous target genes including those associated
with the anti-apoptotic response (Ryu et al., 2005). In short, 4-
PB can influence the transcription of wide range of genes by
influencing the epigenetic control of gene expression and the
covalent regulation of transcription factor activity. This may
explain its reported ability to moderate the UPR and UPR-
mediated apoptosis (Vilatoba et al., 2005; Basseri et al., 2009; Yue
et al., 2016).
Despite this, the specific cellular response to 4-PB depends on
cell context. For example, 4-PB can be pro-apoptotic in myeloid
leukemia cells (DiGiuseppe et al., 1999) and prostate cancer cells
(Melchior et al., 1999). The question as to whether 4-PB might
have therapeutic value in treating AI was investigated when
female mice heterozygous for the Amelxp.(Y64H) mutation were
fed 4-PB in their diet. A dramatic rescue of the AI phenotype
resulted (Brookes et al., 2014). In this context, 4-PB did not
restore AMELX secretion as might be expected were it to be
acting as a synthetic chaperone. Instead, 4-PB appeared to inhibit
apoptosis in the 50% of ameloblasts expressing Amelxp.(Y64H).
This presumably allowed the remaining ameloblasts expressing
WT AMELX to complete amelogenesis. It is possible that
AMELX synthesis and secretion was increased in the unaffected
ameloblasts and that this compensated for the fact that only half
the ameloblasts were secreting matrix.
It is currently unknown whether or not 4-PB treatment can
rescue the enamel phenotype in cases of AI other than that
in female mice heterozygous for the Amelxp.(Y64H) mutation.
However, restoring a stalled secretory pathway or inhibiting the
pro-apoptotic actions of the UPR will not rescue the phenotype
if the mutated protein in question is dysfunctional when it is
secreted into the extracellular matrix.
The suggestion that 4-PB is anti-apoptotic in stressed
ameloblasts is further supported by the report that apoptosis
triggered by exposure to fluoride in an ameloblast-derived
cell line was inhibited by 4-PB, resulting in an anti-apoptotic
BCL2/BAX ratio (Suzuki et al., 2017). However, 4-PB was unable
to completely prevent fluorosis in mice drinking fluoridated
water though it did improve some aspects of the condition
compared to control animals who did not receive 4-PB. The
failure of 4-PB to rescue fluorosis could be explained if its effect
was limited to inhibiting apoptosis whilst having no influence
over the effect of fluoride in downregulating KLK4 expression.
An alternative option to treat fluorosis would be to target
the oxidative stress that is triggering the UPR in the first place.
Numerous studies have shown that antioxidants can counter the
oxidative damage caused by fluoride in bone and soft tissues. For
example, fisetin, an anti-oxidant polyphenol flavonoid, protects
against fluoride-induced oxidative damage in osteoblast cell lines
(Inkielewicz-Stepniak et al., 2012) and pretreating rats with the
flavonoid silymarin protected against fluoride-induced oxidative
stress in the brain. In the case of enamel, Suzuki et al. (2014)
reported that a diet enriched with the antioxidant vitamin
E had no protective effect against enamel fluorosis in mice
drinking 50 ppm fluoride. More recently, it was reported that
the antioxidant carotenoid lycopene inhibited fluoride induced
ameloblast apoptosis and enamel fluorosis in rats by combating
oxidative stress (Li et al., 2017). However, the efficacy of such
agents against enamel fluorosis in humans remains unknown.
FUTURE PERSPECTIVE
The phenotypic rescue of female mice heterozygous for
Amelxp.(Y64H) proves the principle that AI driven by ER stress and
a pro-apoptotic UPR can be treated therapeutically with 4-PB. 4-
PB is an approved therapeutic for urea cycle disorders. Acting
as an excretable ammonium scavenger, 4-PB is administered
orally in high doses from birth. However, 4-PB is contraindicated
during pregnancy and so its therapeutic value would be restricted
to protecting those permanent teeth whose enamel begins to
mineralize after birth.
Clearly, more research is required using relevant mouse
models to establish how common ER stress is as an etiological
factor in human AI and how appropriate is targeting ER stress
and the UPR as a treatment option. There are numerous other
compounds under investigation for their therapeutic potential
in terms of influencing folding of mutated proteins, inhibiting
aggregation of mutated proteins and modulating the UPR.
(Schonthal, 2012; Denny et al., 2013) and these may be more
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effective than 4-PB for treating specific cases of AI depending
on the mutation involved. To treat AI in patients with such
compounds, it would first be necessary to establish that ER stress
was involved in the etiology in each case and then identify the
most effective therapeutic agent able to combat the effects of the
specific mutation involved in a personalized medicine approach
using cell models.
In summary, ER stress and the UPR play an important role
in maintaining ameloblast function and proteostasis under high
secretory load during amelogenesis. We also know that it plays
a role in the etiology of enamel pathology, and that, at least
in some cases, AI can now be added to the growing list of
proteopathic diseases. Proteopathies include several of the major
diseases of our age and there is intense research underway
to identify compounds of therapeutic value. It is an exciting
possibility that anti-proteopathic drugs may provide an effective
treatment option in amenable cases of AI. Fluorosis is not a
classic proteopathic disease but the etiological involvement of
the UPR raises the possibility that drugs that can modulate the
UPR, or control the oxidative stress triggering the UPR, may be
of therapeutic value in areas where fluorosis is endemic.
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